BEST ABSTRACT: A phase 3, randomized, double-blind, placebo-controlled study of tasquinimod (TASQ) in men with metastatic castrate resistant prostat...

Date 28 September 2015
Event European Cancer Congress 2015
Session Presidential Session III
Topics Prostate Cancer
Presenter Carducci, M.